Our Commitment

We're committed to growing our research in Regenerative Medicine in both the UK and US as part of an emerging new business venture at the cutting edge of science. Here, we're both focusing on stem cells and modulators of the regenerative processes – both small molecules and biotherapeutic therapies.

We're building a biotechnology environment based on innovation. Our small, flexible teams and the common drive to make science benefit patients as quickly as possible mean we'll be able to make decisions quickly and effectively.

Our Regenerative Medicine capabilities are complemented by the best Pfizer has to offer: a vast array of drug discovery technologies; the R&D resources and experience only a big pharmaceutical company can offer; a nimble and growing biotherapeutics organisation; and a growing network of alliances and collaborations.